Keyphrases
Acute Respiratory Distress Syndrome
100%
TRP Channels
100%
Cannabichromene
100%
Transient Receptor Potential Vanilloid 1 (TRPV1)
25%
Inhalants
25%
Placebo
16%
Sham
16%
Protective Effect
16%
Inflammatory Diseases
16%
Lung Tissue
16%
Therapeutic Modalities
16%
Poly IC
16%
Cannabinoids
16%
Lung
8%
Inflammatory Cytokines
8%
Male Mice
8%
C57BL
8%
Immunohistochemistry
8%
Hypoxia
8%
Health Systems
8%
Homeostasis
8%
Statistical Analysis
8%
Double-stranded RNA
8%
Quality of Life
8%
Therapeutic Target
8%
Putative Drug Targets
8%
Further Analysis
8%
Histologic
8%
Human Subjects
8%
Post Hoc Test
8%
Beneficial Effects
8%
Hospitalization Rate
8%
Mortality Rate
8%
Life-threatening
8%
Murine Model
8%
Daily Dose
8%
Once-daily Dosing
8%
Specific Treatment
8%
Effective Alternative
8%
One-way Analysis of Variance
8%
First Dose
8%
Alternative Therapy
8%
Outcome Quality
8%
Alternative Therapeutics
8%
Clinical Syndromes
8%
Transient Receptor Potential Cation Channel
8%
Pulmonary System
8%
Systemic Inflammatory Diseases
8%
Translational Model
8%
O2 Saturation
8%
Intranasal Administration
8%
COVID-19 Pandemic
8%
Immune Balance
8%
Flow Cytometry Method
8%
TRP Cation Channel
8%
TRPV2
8%
Inhaler Devices
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
100%
Transient Receptor Potential Channel
100%
Cannabichromene
100%
Inflammatory Disease
25%
Mouse
16%
Symptom
16%
Placebo
16%
Cannabinoid
16%
Polyinosinic Polycytidylic Acid
16%
Cytokine
8%
Hypoxia
8%
C57BL 6 Mouse
8%
Flow Cytometry
8%
Mortality Rate
8%
Syndrome
8%
Human
8%
Double Stranded RNA
8%
Pandemic
8%